Photodynamic therapy in the management of potentially malignant and malignant oral disorders

Head and Neck Oncology

Volumn 4, Issue 1, 2012, Pages

  Jerjes, Waseem ^a,b,c,d,e,f   Hamdoon, Zaid ^a,b,c,g,h   Hopper, Colin ^d,g,h  

^a Dijla University College   (Iraq)

^b AL YARMOUK UNIVERSITY COLLEGE   (Iraq)

^c MUSTANSIRIYAH UNIVERSITY   (Iraq)

^d ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^e UNIVERSITY OF LEEDS   (United Kingdom)

^f LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

^g UNIVERSITY COLLEGE LONDON   (United Kingdom)

^h UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; PHOTOFRIN; PHOTOSENSITIZING AGENT; TEMOPORFIN; VERTEPORFIN;

DRUG CYTOTOXICITY; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; EDEMA; HOARSENESS; HUMAN; LARYNX CARCINOMA; LASER; LASER SURGERY; LEUKOPLAKIA; LIGHT EMITTING DIODE; MOUTH CANCER; MOUTH CARCINOMA; MOUTH DISEASE; MOUTH SQUAMOUS CELL CARCINOMA; NECK DISSECTION; PAIN; PHOTODYNAMIC THERAPY; PHOTOSENSITIVITY; PHOTOTOXICITY; PRIORITY JOURNAL; REVIEW; SYSTEMIC THERAPY; TREATMENT RESPONSE; GAS LASER; INSTRUMENTATION; LOW LEVEL LASER THERAPY; METHODOLOGY; MOUTH TUMOR; PATHOLOGY; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME;

HUMANS; MOUTH DISEASES; MOUTH NEOPLASMS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; TREATMENT OUTCOME; CARCINOMA, SQUAMOUS CELL; LASER THERAPY; LASERS, GAS;

EID: 84862180583     PISSN: None     EISSN: 17583284     Source Type: Journal    
DOI: 10.1186/1758-3284-4-16     Document Type: Review

References (39)

1. Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classification and present concepts of management. Van der Waal I, Oral Oncol 2009 45 4-5 317 23 18674954
2. Treatment and follow-up of oral dysplasia-a systematic review and meta-analysis. Mehanna HM, Rattay T, Smith J, McConkey CC, Head Neck. 2009 31 12 1600 9 10.1002/hed.21131 19455705
3. Potentially malignant disorders of the oral and oropharyngeal mucosa; present concepts of management. van der Waal I, Oral Oncol. 2010 46 6 423 5 10.1016/j.oraloncology.2010.02.016 20308005
4. Recent advances in Oral Oncology 2007: epidemiology, aetiopathogenesis, diagnosis and prognostication. Bagan JV, Scully C, Oral Oncol. 2008 44 2 103 8 10.1016/j.oraloncology.2008.01.008 18252251
5. Global epidemiology of oral and oropharyngeal cancer. Warnakulasuriya S, Oral Oncol 2009 45 4-5 309 16 18804401
6. Clinicopathological parameters, recurrence, locoregional and distant metastasis in 115T1-T2 oral squamous cell carcinoma patients. Jerjes W, Upile T, Petrie A, Riskalla A, Hamdoon Z, Vourvachis M, Karavidas K, Jay A, Sandison A, Thomas GJ, Kalavrezos N, Hopper C, Head Neck Oncol. 2010 2 9 10.1186/1758-3284-2-9 20406474
7. Invasive front in oral squamous cell carcinoma: image and flow cytometric analysis with clinicopathologic correlation. Noguchi M, Kinjyo H, Kohama GI, Nakamori K, Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002 93 6 682 7 10.1067/moe.2002.122341 12142875
8. Clinicopathological parameters and outcome of 245 patients operated for oral squamous cell carcinoma. Garzino-Demo P, Dell'Acqua A, Dalmasso P, Fasolis M, La Terra Maggiore GM, Ramieri G, Berrone S, Rampino M, Schena M, J Craniomaxillofac Surg 2006 34 6 344 50 10.1016/j.jcms.2006.04.004 16859913
9. Current concepts in management of oral cancer - surgery. Shah JP, Gil Z, Oral Oncol 2009 45 4-5 394 401 18674952
10. Current concepts of management in radiotherapy for head and neck squamous-cell cancer. Mazeron R, Tao Y, Lusinchi A, Bourhis J, Oral Oncol 2009 45 4-5 402 8 19375379
11. Current concepts for the management of head and neck cancer: chemotherapy. Specenier PM, Vermorken JB, Oral Oncol 2009 45 4-5 409 15 18715812
12. Photodynamic therapy: a clinical reality in the treatment of cancer. Hopper C, Lancet Oncol. 2000 1 212 9 10.1016/S1470-2045(00)00166-2 11905638
13. The application of photodynamic therapy in the head and neck. Jerjes W, Upile T, Betz CS, El Maaytah M, Abbas S, Wright A, Hopper C, Dent Update 2007 34 8 478 80 18019486
14. Ultrasound-guided photodynamic therapy for deep seated pathologies: prospective study. Jerjes W, Upile T, Hamdoon Z, Nhembe F, Bhandari R, Mackay S, Shah P, Mosse CA, Brookes JA, Morley S, Hopper C, Lasers Surg Med. 2009 41 9 612 21 10.1002/lsm.20853 19827147
15. Photodynamic therapy of malignant and premalignant lesions in patients with 'field cancerization' of the oral cavity. Grant WE, Hopper C, Speight PM, Macrobert AJ, Bown SG, J Laryngol Otol. 1993 107 12 1140 5 8289004
16. Photodynamic therapy using 5-aminolevulinic acid for premalignant and malignant lesions of the oral cavity. Fan KF, Hopper C, Speight PM, Buonaccorsi G, MacRobert AJ, Bown SG, Cancer. 1996 78 7 1374 83 10.1002/(SICI)1097- 0142(19961001)78:7<1374::AID-CNCR2>3.0.CO;2-L 8839541
17. Photodynamic Therapy of oral dysplasia with topical 5-aminolevulinic acid and light-emitting diode array. Tsai JC, Chiang CP, Chen HM, Huang SB, Wang CW, Lee MI, Hsu YC, Chen CT, Tsai T, Lasers Surg Med. 2004 34 1 18 24 10.1002/lsm.10250 14755421
18. Photodynamic therapy for head and neck dysplasia and cancer. Rigual NR, Thankappan K, Cooper M, Sullivan MA, Dougherty T, Popat SR, Loree TR, Biel MA, Henderson B, Arch Otolaryngol Head Neck Surg. 2009 135 8 784 8 10.1001/archoto.2009.98 19687399
19. Photodynamic therapy treatment of early oral and laryngeal cancers. Biel MA, Photochem Photobiol 2007 83 5 1063 8 10.1111/j.1751-1097.2007.00153.x 17880501
20. mTHPC-mediated photodynamic therapy for early oral squamous cell carcinoma. Hopper C, Kübler A, Lewis H, Tan IB, Putnam G, Int J Cancer. 2004 111 1 138 46 10.1002/ijc.20209 15185355
21. Photodynamic therapy outcome for oral dysplasia. Jerjes W, Upile T, Hamdoon Z, Mosse CA, Akram S, Lasers Surg Med 2011 43 3 192 9 10.1002/lsm.21036 21412802
22. Photodynamic therapy outcome for T1/T2N0 oral squamous cell carcinoma. Jerjes W, Upile T, Hamdoon Z, Alexander Mosse C, Morcos M, Hopper C, Lasers Surg Med 2011 43 6 463 9 10.1002/lsm.21071 21761416
23. Photodynamic therapy: an effective, but non-selective treatment for superficial cancers of the oral cavity. Grant WE, Speight PM, Hopper C, Bown SG, Int J Cancer. 1997 71 6 937 42 10.1002/(SICI)1097-0215(19970611)71:6<937:: AID-IJC4>3.0.CO;2-Z 9185692
24. Photodynamic therapy (PDT) for lung cancers. Usuda J, Kato H, Okunaka T, Furukawa K, Tsutsui H, Yamada K, Suga Y, Honda H, Nagatsuka Y, Ohira T, Tsuboi M, Hirano T, J Thorac Oncol. 2006 1 5 489 93 10.1097/01243894-200606000-00018 17409904
25. Long-term survival of patients treated with photodynamic therapy for carcinoma in situ and early non-small-cell lung carcinoma. Corti L, Toniolo L, Boso C, Colaut F, Fiore D, Muzzio PC, Koukourakis MI, Mazzarotto R, Pignataro M, Loreggian L, Sotti G, Lasers Surg Med. 2007 39 5 394 402 10.1002/lsm.20513 17565719
26. Photodynamic laser therapy for lesions in the airway. Minnich DJ, Bryant AS, Dooley A, Cerfolio RJ, Ann Thorac Surg 2010 89 6 1744 8 discussion 1748-9 10.1016/j.athoracsur.2010.02.025 20494021
27. International Photodynamic Group for High-Grade Dysplasia in Barrett's Esophagus. Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett's high-grade dysplasia. Overholt BF, Wang KK, Burdick JS, Lightdale CJ, Kimmey M, Nava HR, Sivak MV, Nishioka N, Barr H, Marcon N, Pedrosa M, Bronner MP, Grace M, Depot M, Gastrointest Endosc 2007 66 3 460 8 10.1016/j.gie.2006.12.037 17643436
28. Photodynamic therapy with curative intent for Barrett's esophagus with high grade dysplasia and superficial esophageal cancer. Keeley SB, Pennathur A, Gooding W, Landreneau RJ, Christie NA, Luketich J, Ann Surg Oncol. 2007 14 8 2406 10 10.1245/s10434-007-9392-x 17534685
29. Tanaka T, Matono S, Nagano T, Murata K, Sueyoshi S, Yamana H, Shirouzu K, Fujita H Photodynamic therapy for large superficial squamous cell carcinoma of the esophagus, Gastrointest Endosc 2011
30. Use of photodynamic therapy in malignant lesions of stomach, bile duct, pancreas, colon and rectum. Wang JB, Liu LX, Hepatogastroenterology 2007 54 75 718 24 17591048
31. Photodynamic therapy for pancreatic cancer. Fan BG, Andrén- Sandberg A, Pancreas. 2007 34 4 385 9 10.1097/mpa.0b013e3180439c50 17446835
32. Photodynamic therapy for urological malignancies: past to current approaches. Pinthus JH, Bogaards A, Weersink R, Wilson BC, Trachtenberg J, J Urol. 2006 175 4 1201 7 10.1016/S0022-5347(05)00701-9 16515960
33. A phase- 1 study of sequential mitomycin C and 5-aminolaevulinic acid-mediated photodynamic therapy in recurrent superficial bladder carcinoma. Skyrme RJ, French AJ, Datta SN, Allman R, Mason MD, Matthews PN, BJU Int. 2005 95 9 1206 10 10.1111/j.1464-410X.2005.05506.x 15892802
34. Optimization of treatment parameters for Foscan(R)-PDT of basal cell carcinomas. Betz CS, Rauschning W, Stranadko EP, Riabov MV, Albrecht V, Nifantiev NE, Hopper C, Lasers Surg Med. 2008 40 5 300 11 10.1002/lsm.20632 18563776
35. Methylaminolaevulinate-based photodynamic therapy of Bowen's disease and squamous cell carcinoma. Calzavara-Pinton PG, Venturini M, Sala R, Capezzera R, Parrinello G, Specchia C, Zane C, Br J Dermatol. 2008 159 1 137 44 10.1111/j.1365-2133.2008.08593.x 18489606
36. The present and future role of photodynamic therapy in cancer treatment. Brown SB, Brown EA, Walker I, Lancet Oncol. 2004 5 8 497 508 10.1016/S1470-2045(04)01529-3 15288239
37. Photodynamic therapy in oncology. Triesscheijn M, Baas P, Schellens JH, Stewart FA, Oncologist. 2006 11 9 1034 44 10.1634/theoncologist.11-9-1034 17030646
38. A systematic review of photodynamic therapy in the treatment of pre-cancerous skin conditions, Barrett's oesophagus and cancers of the biliary tract, brain, head and neck, lung, oesophagus and skin. Fayter D, Corbett M, Heirs M, Fox D, Eastwood A, Health Technol Assess. 2010 14 37 1 288 21208547
39. Interstitial PDT for vascular anomalies. Jerjes W, Upile T, Hamdoon Z, Mosse CA, Akram S, Morley S, Hopper C, Lasers Surg Med. 2011 43 5 357 65 10.1002/lsm.21058 21674540